Gold, Silver’s Next Leg: Speculators Are the ‘Main Engine,’ Says Thornton
Dr. Mark Thornton of the Mises Institute sees speculators as the "main engine" for gold and silver's next price rally. He states...

Dr. Mark Thornton of the Mises Institute sees speculators as the "main engine" for gold and silver's next price rally. He states...

Coffee prices surged on Friday, with arabica reaching a 5-week high. Concerns over an impending El Niño weather pattern impacting key growing...

Stock futures show a rebound as crude oil approaches $110 per barrel, with investors keenly awaiting upcoming earnings reports from key artificial...

Royal Gold (NASDAQ:RGLD) announced record financial results and significant debt reduction, driven by its 2025 acquisitions of Sandstorm and Horizon, expanding its...

Cocoa futures saw a sharp decline Friday, with New York and London contracts falling over 3%, following reports of weaker-than-expected Q3 North...

Goldman Sachs indicates potential for further equity gains but advises against concentrating investments in top-performing stocks, suggesting a broader market approach.

MoonLake Immunotherapeutics' investigational drug, sonelokimab, is reportedly facing significant regulatory and commercial scrutiny, according to analysis by RBC.

Market observers are closely monitoring trending stocks as a significant tech sector selloff deepens, leading to heightened market volatility this week.

U.S. stock indexes finished sharply lower Friday, led by a significant -2.50% drop in the Nasdaq 100. The S&P 500 fell -1.09%,...